Bicycle Therapeutics Ltd (BCYC) — Capital Reinvestment Ratio

Latest as of June 2023: 0.01x

Bicycle Therapeutics Ltd (BCYC) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($34.10 Million) in capital expenditures ($277.00K). Check tangible net worth ratio of Bicycle Therapeutics Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$34.10 Million

USD

Capital Expenditures

$277.00K

USD

Data as of

Jun 2023

Most recent filing

Annual Capital Reinvestment Ratio for Bicycle Therapeutics Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Bicycle Therapeutics Ltd from None to None. See Bicycle Therapeutics Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow